Early research suggests Merck cancer drug may target dormant HIV
Antiretroviral treatments now allow many HIV patients to lead normal lives, but the drugs do not completely remove the virus from…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pembrolizumab
US FDA approves KEYTRUDA from Merck for adults with relapsed or refractory cHL
KEYTRUDA is the first anti-PD-1 therapy approved for adult patients with relapsed or refractory cHL after frontline therapy